Ainos Inc.
0.68
0.10 (17.22%)
At close: Jan 14, 2025, 3:59 PM
0.67
-1.02%
After-hours Jan 14, 2025, 07:57 PM EST
undefined%
Bid 0.65
Market Cap 9.57M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.71
PE Ratio (ttm) -0.25
Forward PE n/a
Analyst n/a
Ask 0.7
Volume 1,187,462
Avg. Volume (20D) 582,098
Open 0.59
Previous Close 0.58
Day's Range 0.58 - 0.77
52-Week Range 0.40 - 3.10
Beta undefined

About AIMD

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-...

Industry Biotechnology
Sector Healthcare
IPO Date Jan 8, 2021
Employees 46
Stock Exchange NASDAQ
Ticker Symbol AIMD
5 months ago · Source
+8.06%
Ainos shares are trading higher after the company ... Unlock content with Pro Subscription
5 months ago · Source
+1.2%
Ainos shares are trading higher after the company announced that it has obtained exclusive licenses for a total of 10 invention patents and patent applications from Taiwan Carbon Nano Technology.